The New York Eye Cancer Center (NYECC) is a world-class facility for the diagnosis and treatment of eye cancer. Founded in 1995, Dr. Finger has treated many thousands of patients.
What does it mean to be world-class?
- Patients travel from 6 continents to receive treatment by Dr. Finger.
- Dr. Finger operates a pathbreaking original research program which has developed new methods of diagnosis and eye cancer treatments in use worldwide today.
- Dr. Paul T. Finger is the Chair of Ocular Oncology for the American Joint Committee on Cancer, the Ophthalmic Representative for the Commission on Cancer and the International Union for Cancer Care (UICC). He has written THE chapter on intraocular melanoma for DeVita’s 10th and 11th editions of his Medical Oncology Textbook, “Cancer.”
Dr. Finger and his staff at NYECC work closely with patients and referring doctors to provide advanced treatment in a responsive, caring environment.
Meet Dr. Finger
Paul T. Finger, M.D., F.A.C.S. is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and a Life Member of the American Academy of Ophthalmology. He is the founding Director of Ocular Tumor Services at several renowned institutions.
The New York Eye Cancer Center’s doctors and staff are passionate about helping patients manage and treat ocular tumors. They bring decades of experience, research and personal care to their work, as well as happy, positive attitudes. Patients often say, we create a caring and efficient environment for our patients.
The New York Eye Cancer Center maintains affiliations with three of New York City’s leading hospitals in the treatment of ocular cancer. Our patients have access to their highly trained staff, modern facilities, and advanced diagnostic technology.
NYECC In The News
Stay up-to-date with the latest press about The New York Eye Cancer Center and Dr. Finger’s groundbreaking research.